Sex-specific disruptions in PKCγ signaling in a mouse model of spinocerebellar ataxia type 14
Authors:
- Sarah A. WolfeSWSarah A. Wolfe
- Yuliang MaYMYuliang Ma
- Tomer M. Yaron-BarirTYTomer M. Yaron-Barir
- Carly ChangCCCarly Chang
- Caila A. PiloCPCaila A. Pilo
- Majid GhassemianMGMajid Ghassemian
- Amanda J. RobertsARAmanda J. Roberts
- Sang Ryeul LeeSLSang Ryeul Lee
- Benjamin A. HensonBHBenjamin A. Henson
- Kristen JepsenKJKristen Jepsen
- Jared L. JohnsonJJJared L. Johnson
- Lewis C. CantleyLCLewis C. Cantley
Open Access
- 26 March 2026
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 11 (10)
Abstract
Spinocerebellar ataxia type 14 (SCA14) is an autosomal dominant neurodegenerative disease caused by mutations in the gene encoding protein kinase C γ (PKCγ), a Ca 2+ - and diacylglycerol-dependent Ser/Thr kinase dominantly expressed in cerebellar Purkinje cells. These mutations impair autoinhibitory constraints to increase the basal activity of the kinase, resulting in deficits in the cerebellum that are not observed upon simple deletion of the gene, and severe ataxia. To better understand the impact of aberrant PKCγ signaling in disease pathology, we developed a knockin murine model of the SCA14 mutation ΔF48 in PKCγ. This fully penetrant mutation is severe in humans and is mechanistically informative, as it has high basal activity but is unresponsive to agonist stimulation. Genetic, behavioral, and molecular testing revealed that ΔF48 PKCγ mice have ataxia-related phenotypes and an altered cerebellar phosphoproteome driven primarily by enhanced Ca 2+ /calmodulin-dependent kinase 2 signaling, effects that were more severe in male mice. Analysis of existing human data revealed that SCA14 has a significantly earlier age of onset for males compared with females. Data from this clinically relevant mutation suggested that enhanced basal activity of PKCγ is sufficient to cause ataxia and that treatment strategies to modulate aberrant PKCγ may be particularly beneficial in males.Keywords
Funding Information
- NIH (R35 GM122523,R01 NS120725,P30 CA023100,P30 DK063491)
- NIH (R35 GM122523,R01 NS120725,P30 CA023100,P30 DK063491,R35 CA197588,P01 CA120964,P01 CA117969,S10 OD026929)
- NIH (R35 GM122523,R01 NS120725,P30 CA023100,P30 DK063491,R35 CA197588,P01 CA120964,P01 CA117969,S10 OD026929)
- NIH (R35 GM122523,R01 NS120725,P30 CA023100,P30 DK063491,R35 CA197588,P01 CA120964,P01 CA117969,S10 OD026929)
This publication has 104 references indexed in Scilit:
- Cerebellum in Alzheimer's disease and other neurodegenerative diseases: an emerging research frontierMedcomm, 2024
- Gene Set Knowledge Discovery with EnrichrCurrent Protocols, 2021
- Spinocerebellar ataxia type 14: refining clinicogenetic diagnosis in a rare adult‐onset disorderAnnals of Clinical and Translational Neurology, 2021
- Protein kinase CIUBMB Life, 2008
- Another Mutation in Cysteine 131 in Protein Kinase Cγ as a Cause of Spinocerebellar Ataxia Type 14Archives of Neurology, 2007
- Mutation in the Catalytic Domain of Protein Kinase C γ and Extension of the Phenotype Associated With Spinocerebellar Ataxia Type 14Archives of Neurology, 2004
- Spinocerebellar Ataxia Type 14 Caused by a Mutation in Protein Kinase C γArchives of Neurology, 2003
- Regional and cellular distribution of protein kinase C in rat cerebellar purkinje cellsJournal of Comparative Neurology, 2000
- A novel locus for dominant cerebellar ataxia (SCA14) maps to a 10.2-cM interval flanked by D19S206 and D19S605 on chromosome 19q13.4-qterAnnals of Neurology, 2000
- 17β-Estradiol regulation of protein kinase C activity in chondrocytes is sex-dependent and involves nongenomic mechanismsJournal of Cellular Physiology, 1998